Literature DB >> 3322203

[Drugs in pregnancy].

K Knörr.   

Abstract

Mesh：

Year:  1987        PMID： 3322203     DOI： 10.1007/BF00930986

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


× No keyword cloud information.
  11 in total

1.  Metronidazole treatment in pregnancy.

Authors:  I Morgan
Journal:  Int J Gynaecol Obstet       Date:  1978       Impact factor: 3.561

2.  Teratogenicity of isotretinoin.

Authors:  F W Rosa
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

3.  Valproic acid and spina bifida.

Authors:  T Bjerkedal; A Czeizel; J Goujard; B Kallen; P Mastroiacova; N Nevin; G Oakley; E Robert
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

4.  Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.

Authors:  W Grote; D Harms; U Jänig; H Kietzmann; U Ravens; I Schwarze
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

Review 5.  The effects of cancer chemotherapeutic agents on the developing fetus.

Authors:  J Gililland; L Weinstein
Journal:  Obstet Gynecol Surv       Date:  1983-01       Impact factor: 2.347

Review 6.  Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts).

Authors:  H Kalter; J Warkany
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

7.  Diethylstilbestrol exposure--1984.

Authors:  A L Herbst
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

8.  Virilization of the female fetus with maternal danazol exposure.

Authors:  F W Rosa
Journal:  Am J Obstet Gynecol       Date:  1984-05-01       Impact factor: 8.661

9.  [Pregnancy and fetal development in epileptic women].

Authors:  D Janz
Journal:  Geburtshilfe Frauenheilkd       Date:  1984-07       Impact factor: 2.915

Review 10.  Acute leukemia and pregnancy: a review of management and outcome, 1972-1982.

Authors:  V A Catanzarite; J E Ferguson
Journal:  Obstet Gynecol Surv       Date:  1984-11       Impact factor: 2.347
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.